Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Practice Point
  • Published:

Does the number of prostate biopsies performed affect the nature of the cancer identified?

Nature Clinical Practice Urology volume 4, pages 132–133 (2007)Cite this article

boxed-textMeng MV et al. (2006) Impact of increased number of biopsies on the nature of prostate cancer identified. J Urol 176: 63–68

Background

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. Derweesh IH et al. (2004) Continuing trends in pathological stage migration in radical prostatectomy specimens. Urol Oncol 22: 300–306

    Article  Google Scholar 

  2. Presti JC Jr (2003) Prostate biopsy: how many cores are enough? Urol Oncol 21: 135–140

    Article  Google Scholar 

  3. Stewart CS et al. (2001) Prostate cancer diagnosis using a saturation needle biopsy technique after previous negative sextant biopsies. J Urol 166: 86–91

    Article  CAS  Google Scholar 

  4. Klotz LH and Nam RK (2006) Active surveillance with selective delayed intervention for favorable risk prostate cancer: clinical experience and a 'number needed to treat' analysis. Can J Urol 13 (Suppl 1): S48–S55

    Google Scholar 

Download references

Acknowledgements

The synopsis was written by Tamsin Osborne, Associate Editor, Nature Clinical Practice.

Author information

Author notes

  1. Section of Urology and Renal Transplantation, Virginia Mason Medical Center, 1100 Ninth Avenue, Seattle, WA 98101, USA christopher.porter@vmmc.org

Authors and Affiliations

  1. CR Porter is Co-Director of Urologic Oncology in the Section of Urology and Renal Transplantation at Virginia Mason Medical Center, Seattle, WA, USA.,

    Christopher R Porter

Authors
  1. Christopher R Porter
    View author publications

    You can also search for this author in PubMed Google Scholar

Ethics declarations

Competing interests

The author declares no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Porter, C. Does the number of prostate biopsies performed affect the nature of the cancer identified?. Nat Rev Urol 4, 132–133 (2007). https://doi.org/10.1038/ncpuro0712

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ncpuro0712

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing